The activating receptor NKG2D was significantly less frequently expressed among iNKT cells, total NK cells and CD56dim NK cells of PBMC of NAFLD patients compared to healthy controls. This evidence concerns the gene KLRK1 and metabolic dysfunction-associated steatotic liver disease.